Advisors
Dr. Harvey E. Bale, Jr. is widely recognized as a leader in the fight against counterfeiting. As Director-General of the Geneva-based International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), he represented the research-based pharmaceutical industry and other manufacturers of prescription medicines, coordinating with the World Health Organization (WHO), the World Trade Organization (WTO) as well as other international organizations concerned with health and trade-related issues. As Director-General, he served as founding President of the Pharmaceutical Security Institute (PSI), an industry organization dedicated to combating counterfeiting. He was also a key collaborator in the establishment of the World Health Organization International Medical Products Anti-Counterfeiting Task Force (WHO IMPACT) and served as the first Chair of its Technology Subcommittee. Dr. Bale has prior experience with the Pharmaceutical Research and Manufacturers of America as Senior Vice President for International Affairs, at Hewlett-Packard, and in the Office of the U.S. Trade Representative, in trade negotiations and in the Camp David negotiations on the settlement of Israeli/Palestinian issues. In 1986 he received the Distinguished Service Award from U.S. President Ronald Reagan, the highest award given to senior career government executives.
Emil W. Ciurczak is a leading expert in spectroscopy, with over 30 years of pharmaceutical experience at companies such as Sandoz, Ciba-Geigy, Merck, and Purdue. He holds multiple patents in spectroscopy. His experience includes patents on a non-invasive blood glucose monitor and another on the supporting software; 40 years of pharmaceutical analysis experience, 25 years of near-infrared experience, 30 years of college-level teaching experience, and numerous technical publications. He lectures frequently and provides training courses on spectroscopic techniques and applications. He literally wrote the book on the topic, with the third edition published in 2007.
Donna Romer recently was COO of Celartem Technology and CEO of Celartem USA. She has 20-plus years of experience in executive leadership, beginning at Kodak. She founded Romer + Associates, a successful M&A practice, where she provided deal leadership, channel expansion and company integration services. Prior to that, she worked in the venture capital community as Entrepreneur-in-Residence for EastWest VentureGroup, a California VC with focus on the rich media and internet infrastructure space. She also holds several patents.
David Ian Forbes, CEO of Emantix, brings to InfraTrac over two decades experience in usability, information and interaction design, and advertising and marketing. Before Emantix, he was CEO of Contextware, which he founded in 2001. Contextware offered commercial and government organizations a highly innovative method for managing institutional knowledge, and among his many patented innovations, reinvented business process methods so that business processes could be modeled and managed over the internet using simple web interfaces. Prior to Contextware, he was responsible for branding, product marketing and usability engineering for a Kodak digital asset technology spin off. He has also worked in corporate marketing, for advertising agencies, and in film and video production.
Dr. Howard Mark, of Mark Electronics, consults with InfraTrac on NIR. The founder of The Near Infrared Research Corporation and the winner of the EAS award for Achievement in Near Infrared Spectroscopy for 2003, Dr. Mark has worked with NIR since 1976 when he joined Technicon Instrument Corp. In the R&D department, Dr. Mark implemented many "firsts" for NIR. He created the first universal calibration, performed the first application of NIR to many industries, designed the first extended-range filter instruments and internal-reference double-beam monochromator instruments, created the first qualitative analysis software for NIR. He designed, developed, modified and optimized the instruments and associated software and ensured that the instruments performed their functions to the level needed to satisfy the user requirements. In the Applications department, he worked with customers in the chemical and other industries to install, implement, calibrate the instruments and ensure that the entire installation met the customer's needs. He is now an independent consultant for NIR, helping instrument developers (both start-ups and established companies) and users (pharmaceutical, medical devices and other companies) get the most out of NIR. Dr. Mark also teaches NIR courses in Amsterdam and New Brunswick under the auspices of the Center for Professional Advancement, and also privately.